[Adult histiocytosis X with multiple localizations. 6 year course and therapeutic discussion].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000309:Adrenal Insufficiency / Q000175:diagnosis / Q000209:etiology; D000328:Adult; D002699:Chlorambucil / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D003919:Diabetes Insipidus / Q000209:etiology; D006801:Humans; D007571:Jaw Diseases / Q000209:etiology; D008206:Lymphatic Diseases / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D008297:Male; D009765:Obesity / Q000209:etiology; D011030:Pneumothorax / Q000209:etiology* / Q000601:surgery; D011379:Prognosis; D012129:Respiratory Function Tests; D012131:Respiratory Insufficiency / Q000209:etiology; D012272:Ribs / Q000601:surgery; D012877:Skin Manifestations; D013896:Thoracic Diseases / Q000601:surgery; D014747:Vinblastine / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D002699:Chlorambucil; D014747:Vinblastine; D003520:Cyclophosphamide
Histiocytose X de l'adulte á localisations multiples. Evolution sur 6 ans et discussion thérapeutique.